Mobile Power Unit AC Power Cord Recall: Abbott Medical Removes AC Power Cord Associated with HeartMate Mobile Power Unit (MPU) Due to Potential Risk of the Cord Not Locking into Place

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it.   Affected Product Product Name: AC Power Cord (model: 107760) for the HeartMate Mobile Power Unit (model: 107754)…

Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings

Summary Company Announcement Date: August 28, 2025 FDA Publish Date: August 29, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Undeclared prescription drug-Tadalafil Company Name: Green Lumber Holding, LLC. Brand Name: Brand Name(s) Green Lumber Product Description: Product Description Dietary Supplement Company Announcement Costa Mesa, California August 28, 2025 – Green Lumber Holding,…

Unichem Pharmaceuticals (USA) Inc. Issues Voluntary Nationwide Recall of Cyclobenzaprine Hydrochloride Tablets USP 10 mg, Due to Mislabeling

Summary Company Announcement Date: August 27, 2025 FDA Publish Date: August 27, 2025 Product Type: Drugs Reason for Announcement: Recall Reason Description Device & Drug Safety – Mislabel Company Name: Unichem Pharmaceuticals Brand Name: Brand Name(s) Unichem Pharmaceuticals Product Description: Product Description Cyclobenzaprine Hydrochloride Tablets USP 10 mg Company Announcement FOR IMMEDIATE RELEASE – 08/27/2025–…

FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication

AUDIENCE: Patient, Health Care Professional, Pharmacy, Cardiology, Neurology, Internal Medicine, Family Practice, Travel Clinics UPDATE: On August 22, 2025, the US FDA’s Center for Biologics Evaluation and Research (CBER) has suspended the biologics license for Valneva Austria GmbH’s Ixchiq (Chikungunya Vaccine, Live). This vaccine was initially approved by FDA under the accelerated approval pathway in…

Vascular Stent Recall: Boston Scientific Removes Carotid WALLSTENT Monorail Endoprosthesis Due to Risk of Resistance During Device Withdrawal

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product Product Name Lot Number UDI-DI (GTIN) CAROTID WALLSTENT MONORAIL 10.0-24 H7493915010240 08714729781097 CAROTID WALLSTENT MONORAIL…